The roles of most cytoskeletal proteins in platelet formation and function remain largely undefined. We earlier detected megakaryocyte membrane blebbing and a unique antigenic determinant associated with a missense mutation in the cytoskeletal protein, talin, in an animal model of hereditary macrothrombocytopenia, the Wistar Furth (WF) rat, which led us t o examine the distribution of talin and other cytoskeleta1 proteins in resting normal and WF rat platelets. In contrast to the conclusions of an earlier ultrastructural analysis, our biochemical and ultrastructural immunogold studies indicate a significant membrane-association of talin in both resting normal and WF rat platelets as found earlier for rat megakaryocytes. Talin was associated with plasma membranes, membranes of the surface-connected canalicular system, and with a-granule membranes of both normal and LATELETS ARE RICH in cytoskeletal proteins that regulate the contractile responses of these cells.' Circulating platelets are rapidly transformed to an active state by a series of coordinated steps involving changes of shape, granule content, and membrane organization. These processes are closely linked to changes in the organization of the cytoskeleton.' In the resting platelet, cytoskeletal proteins may play a structural and metabolic role, while during activation, they are reported to play a mechanochemical role? Most attention has been focused on changes in the subcellular redistribution of cytoskeletal proteins upon platelet activation, whereas the interaction of cytoskeletal proteins in resting platelets has not been well studied.
The roles of most cytoskeletal proteins in platelet formation and function remain largely undefined. We earlier detected megakaryocyte membrane blebbing and a unique antigenic determinant associated with a missense mutation in the cytoskeletal protein, talin, in an animal model of hereditary macrothrombocytopenia, the Wistar Furth (WF) rat, which led us t o examine the distribution of talin and other cytoskeleta1 proteins in resting normal and WF rat platelets. In contrast to the conclusions of an earlier ultrastructural analysis, our biochemical and ultrastructural immunogold studies indicate a significant membrane-association of talin in both resting normal and WF rat platelets as found earlier for rat megakaryocytes. Talin was associated with plasma membranes, membranes of the surface-connected canalicular system, and with a-granule membranes of both normal and LATELETS ARE RICH in cytoskeletal proteins that regulate the contractile responses of these cells.' Circulating platelets are rapidly transformed to an active state by a series of coordinated steps involving changes of shape, granule content, and membrane organization. These processes are closely linked to changes in the organization of the cytoskeleton.' In the resting platelet, cytoskeletal proteins may play a structural and metabolic role, while during activation, they are reported to play a mechanochemical role? Most attention has been focused on changes in the subcellular redistribution of cytoskeletal proteins upon platelet activation, whereas the interaction of cytoskeletal proteins in resting platelets has not been well studied.
This analysis of cytoskeletal proteins in resting platelets was prompted by our detection of megakaryocyte membrane blebbing and a unique antigenic determinant4 associated with a missense mutation in talin of Wistar Furth (W) rats5 Talin is expressed in many tissues, but its highest expression is in platelets where it constitutes 3% to 8% of total platelet protein? The high level of talin in platelets suggests an important role for this protein in actin-based contractility of platelets: because talin is associated with actin filaments in WF rat platelets, but as in WF megakaryocytes, talin was absent from the large membrane complexes of WF platelets.
An even more striking difference was seen in the distribution of myosin in subcellular fractions of normal and WF rat platelets separated in density gradients, in which the proportion of myosin in the least dense WF rat platelet membrane fraction was one half that in the same normal platelet fraction. This difference was balanced by a fourfold increase in myosin in the most dense WF rat subcellular fraction, which is highly enriched for a-granules. These results support our hypothesis that the platelet abnormalities of the WF rat are related t o defects in the megakaryocyte-platelet cytoskeleton.
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focal contacts present in the periphery of adherent cells,'38 and binds to actin filaments in vitro. '.l0 From this localization pattern, talin has been hypothesized to serve as a link between actin filaments and the plasma Because the platelet formation defects of the WF rat occur during megakaryocyte differentiati~n,""~ we earlier examined whether talin was membrane-associated in normal and WF rat megakaryocytes, and whether talin distribution was normal in WF megakaryocytes. 4 Indeed, although WF megakaryocytes showed abnormalities in talin distribution, a substantial proportion of megakaryocyte talin was found to be membrane-associated in both normal and WF rat megakaryocyte^.^ Membrane association of talin in megakaryocytes contrasted with the reported diffuse, nonmembrane association of talin in resting platelets.""s Together, these observations suggested that a portion of talin is membrane-associated in the megakaryocyte and then dissociates from membranes when platelets are formed and released into the circulation. To examine the hypothesis that W F rat platelets have cytoskeletal defects, and the hypothesis that talin dissociates from the platelet membrane after release into the circulation, we have performed detailed biochemical and ultrastructural immunogold analyses of the subcellular distribution of platelet cytoskeletal proteins in WF versus normal rats. Our results indicate that a substantial portion of talin is membrane-associated in both megakaryocytes and platelets, and that the subcellular distribution of myosin and talin is altered in WF rat platelets.
MATERIALS AND METHODS
Retired-breeder male Wistar rats and WF rats were obtained from Harlan Industries (Indianapolis, IN). Polyclonal rabbit antihuman platelet talin antibody was kindly provided by Dr Mary Beckerle (University of Utah, Salt Lake City, UT). Affinity-purified polyclonal goat antibody to human fibrinogen was purchased from Accurate Chemical 65 Scientific Corp (Westbury, NY). Monoclonal antibodies (MoAbs) against talin (8d4) and vinculin (VIN-11-5) were obtained from Sigma Chemical CO (St Louis, MO). MoAb to actin (C4) was purchased from Boehringer Mannheim Corp (Indianapolis, IN). MoAb to myosin (2F12.A9) was obtained from AMAC, Inc (Westbrook, ME).
Collection and preparation of platelets for biochemical studies. Blood was collected from the abdominal aorta of metofane-anesthetized rats into syringes containing ACD (0.13 m o m citric acid; 0.15 mol/L sodium citrate; 0.1 moVL dextrose)/8 pmoI/L prostaglandin E, (PGE,) anticoagulant (1:9, anticoagu1ant:blood). Platelets were separated from other blood cells by differential centrifugation (1,470g for Wistar platelets and 1,138g for W). The length of centrifugation time was the same for both Wistar and WF rat blood, and was determined by the volume of blood. For example, 14 mL of blood was centrifuged for 6 minutes. A lower centrifugation force was required to pellet WF rat platelets because of their larger size. Platelets to be solubilized for electrophoresis without subcellular fractionation were pelleted, washed three times in EHS buffer [0.001 molL Na,EDTA, 0.01 mom HEPES buffer, (Sigma) and 0.15 moV L NaCl], pH 7.6, and the pellets finally suspended in 60 v01 of EHS buffer.I6 To eliminate contaminating red blood cells often present in low concentrations in WF platelet preparations, a density gradient centrifugation step with sodium metrizoate" was included when necessary. In that case, approximately 25 mL of WF platelet-rich plasma was gently layered on top of IO mL of diluted metrizoate (2 parts stock 32.8% sodium metrizoate [Accurate Chemical & Scientific; density of 1.20 g/mL], diluted with 1 part distilled water to a density of 1.13 g/mL). The metrizoate gradients were centrifuged for 20 minutes at 2,950g for Wistar and 2,700g for WF platelets, at room temperature. The platelets banded at the plasma-metrizoate interface, whereas the red blood cells pelleted at the bottom of the tubes. The platelet band was removed, diluted with TRIS-citrate buffer, pH 6.5, (63 mmom TRIS base, 95 mmoUL NaCI, 5 mmoV L KCI, 12 mmoVL citric acid)" with PGEI, and the platelets pelleted and washed three times in this buffer. For subcellular fractionation experiments, the washed platelets were suspended in IO mL of the above TRIS-citrate buffer, pH 6.5,18 with PGE, and protease inhibitors, including 1 mg/mL leupeptin, 8 mg/mL benzamidine-HCl, and 2 mmol/L phenylmethyl-sulfonylfluoride, and stored overnight at 4°C.
Isolation of platelet fractions. The following morning, platelets were pelleted at 2,950g for Wistar and 2,7008 for WF, for 20 minutes at 4°C. Each 1 mL of platelet pellet was resuspended in 4 mL fresh Tris-citrate buffer'* with the above protease inhibitors plus PGEl and placed on ice before cell homogenization. The platelets were homogenized by passage twice through a cold French pressure cell at a pressure of 1, OOO pounds per square inch." The homogenates were centrifuged at 3.200g for 15 minutes at 4°C to pellet debris and undisrupted platelets. The supernatant was layered on top of ice-cold 30% to 60% linear sucrose gradients, containing 8 mmoV L EDTA K?, pH 6.5, and the gradients centrifuged at 35,OOOg for 90 minutes at 4°C. Four discrete regions of platelet organelles were formed in the gradients. The supernatant above the sucrose gradient and the four platelet subcellular organelle regions were collected, the total volume of each fraction measured, and each fraction divided into two parts. One portion of each fraction was diluted with Triscitrate buffer, pH 6.5, and processed for electron microscopy. The other portion was diluted with 10% sucrose for preparation of samples for electrophoresis.
Preparation ofplatelet fractions for electron microscopy. Organelles in fractions 1 and 2 were centrifuged in a Beckman SW 41 Ti rotor (Beckman Instruments, Irvine, CA) at 90,250g for 1 hour at 4°C. Fractions 3 and 4 were centrifuged at 41,000g for 1 hour at 4°C. (Centrifugation of the resulting fraction-3 and -4 supernatants at 300,OOOg showed that most all of the protein was pelleted by the initial centrifugation at 41,OOOg.) Each pellet was resuspended in 10 mL of 1.5% glutaraldehyde in 0.1 m o m cacodylate buffer, pH 7.4 and fixed 2 hours at room temperature. The organelles in each fraction then were pelleted by ultracentrifugation (fractions 1 and 2 at 90,25Og, fractions 3 and 4 at 41,OOOg) for 1 hour at 4"C, rinsed in 0.1 m o m sodium cacodylate buffer, pH 7.4, and post-fixed in 2% osmium tetroxide in 0.1 mom sodium cacodylate buffer for 1.5 hours. The samples then were dehydrated through a graded series of ethanol, infiltrated with toluene and subsequently with Epon resin, and finally embedded in 100% Epon. Thin sections were cut and stained with uranyl acetate and lead citrate, and viewed with a Philips 301 transmission electron microscope (Philips Electronic Instruments, Mahwah, NJ).
Solubilization of platelets and platelet fractions for electrophoresis. Wistar and WF platelets suspended in 60 v01 of EHS buffer were solubilized by boiling in sodium dodecyl sulfate (SDS) as previously reported? Supernatant from the sucrose gradients was collected and diluted 1:l with TRIS-citrate buffer with protease inhibitors and centrifuged at 90,250g for 1 hour at 4°C to eliminate any membrane contamination that may have occurred during fraction collection. One milliliter of supernatant was solubilized by boiling after addition of one-third volume of gel sample buffer containing 0.125 moVL TRIS-HCI, pH 6.8,40% glycerol, 8% SDS, 160 mmoV L dithiothreitol, and 0.01% bromophenol blue. Organelles in sucrose gradient fractions 1 and 2 were pelleted by ultracentrifugation in a Beckman SW 41 Ti rotor at 90,25013 for 1 hour at 4°C. Organelles in fractions 3 and 4 were pelleted at 41,OOOg for 1 hour at 4°C. The pellets were resuspended in EHS buffer (fraction 1,0.5 mL; fractions 2 through 4, 1 mL EHS buffer) and solubilized for electrophoresis by boiling for 5 minutes after addition of a one-third volume of gel sample buffer as described above.
Gel electrophoresis. One-dimensional SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed in 7.5% to 15% linear gradients of acrylamide using the discontinuous buffer system of Laemmli.*" Approximately 30 pg of protein was loaded per lane. Gels were stained with Coomassie blue.
Quantitation of proteins in gels of platelet fractions. The optical density (OD) of selected protein bands in SDS-polyacrylamide gels stained with Coomassie blue was determined using an image analyzer (Bio Image System; Millipore Corporation), and the OD of the bands expressed as a percentage of the total OD of all proteins in the gel lane.
Immunoblotting of antibodies to electrophoretically separated proteins. Proteins separated in polyacrylamide gels were electrophoretically transferred to nitrocellulose sheets in a transfer buffer consisting of 25 mmoVL Trizma base, 192 mmol/L glycine, and 20% methanol. The nitrocellulose strips were incubated overnight with the specific antibodies, washed, incubated with alkaline phosphatase-conjugated goat antimouse IgG, and color developed with an alkaline phosphatase conjugate substrate kit (Bio-Rad Laboratories, Hercules, CA) or with a second antibody conjugated to horseradish peroxidase (HRP) (HRP-conjugated donkey-antimouse IgG; Jackson ImmunoResearcb Laboratories, Inc, West Grove, PA) for antibody detection by the enhanced chemiluminescence (ECL) method (Amersham Corp, Arlington Heights, IL). Two percent casein was included in all incubations and washes to reduce nonspecific binding.
In some cases, after the initial blots were photographed, the same nitrocellulose transfers were probed with another antibody (without removing the initial antibody) so that mobility of the detected antigens could be precisely determined.
Preparation of platelets for ultrastructural immunogold analyses. Whole blood was obtained from the abdominal aorta of rats under metofane anesthesia. Blood was collected from Wistar rats and WF rats (Harlan Industries) into syringes containing ACDPGE, anticoagulant. The blood then was dripped immediately into 9 v01 of 8% paraformaldehyde in 0.1 moVL PIPES buffer, pH 7.2, and fixed for 2 hours at ambient temperature. The whole bloodfixative mixture was centrifuged for 20 minutes at 150g, and the supernatant was spun for 10 minutes at 3,200g to obtain a platelet pellet. The platelet pellet was washed three times by centrifugation (IO minutes at 2,300g) with 0.1 molL PIPES buffer, and then resuspended in the same buffer.
Immunocytochemical procedures. Platelet samples were infiltrated overnight in a mixture of polyvinylpyrrolidone (Sigma) (3.25 For personal use only. on September 24, 2017. by guest www.bloodjournal.org Abbreviations: PM, gold particles on plasma membrane; PM-l00 nm, gold particles within 100 nm of plasma membrane; GR, gold particles on granule membranes; GR-100 nm, gold particles within 100 nm of granules; Other, all cytoplasmic labeling except that on or within 100 n m of granules.
Mean 2 1 SEM. t P < .05 by t-test compared with PM and other, respectively, of Wistar. * P < .025 by t-test compared with PM-l00 nm of Wistar. g), 1.1 m o m sodium carbonate (0.625 mL), and 2.1 m o m sucrose made in phosphate-buffered saline (PBS) (11.75 mL).
The samples were frozen in liquid nitrogen, and ultrathin sections were cut on a Reichert Ultracut E ultramicrotome with an FC-4E frozen thin section attachment (Reichert-Jung Optische Werke Ag, Wien, Austria). The sections were picked up on loops containing 2.1 m o m sucrose, and deposited onto Formvar-coated and carbonstabilized grids. All immunolabeling steps were performed at room temperature. The sections were immunolabeled as follows: The grids were incubated for 10 minutes in PBS containing 1% fish-skin gelatin (Sigma). They were then placed in a blocking solution of PBS containing 1% bovine serum albumin, 10% fetal calf serum, and 10 mmom glycine for 10 minutes. The grids were incubated with primary antiserum, which was diluted in the same buffer for 30 minutes, and then washed in the same buffer 5 times (5 minutes each). Rabbit antiserum to human platelet talin was from Dr Mary Beckerle. Goat antirabbit myosin antibody was kindly provided by Dr John Hartwig (Brigham & Women's Hospital, Boston, MA). In control incubations, nonimmune rabbit or goat serum as appropriate or buffer was used in place of primary antiserum. The grids then were incubated with immunogold probe (either goat-antirabbit IgG conjugated to IO-nm gold particles [Amersham Life Sciences, Arlington Heights, IL] or rabbit-antigoat IgG conjugated to IO-nm gold particles [Sigma]) for 15 minutes. The grids were washed five times in the same buffer (5 minutes each) and then in double-distilled water four times (5 minutes each). They were then stained with filtered oxalate uranyl acetate, pH 7.0, for 5 minutes and washed in double-distilled water four times (5 minutes each). The sections were finally stained and embedded in a mixture of 2% polyvinyl alcohol (Sigma) and 0.2% uranyl acetate (prepared as an aqueous solution and filtered before use), or in methylcellulose and 0.1% to 0.4% uranyl acetate, and viewed with a Philips 301 transmission electron microscope.
RESULTS
Demonstration of membrane association of talin in unstimulated Wistar and Wistar Furth rat platelets. Immunolabeling of frozen thin sections of unstimulated Wistar rat platelets with polyclonal antibodies to talin, followed by immunogold conjugate, showed that talin was localized (1) directly beneath the plasma membrane, (2), in association with a-granule membranes (Fig IA, inset) and surface-connected canalicular system (SCCS) membranes, and (3) diffusely in the cytoplasm, not associated with specific organelles (Fig 1A) . Qualitatively, the talin labeling pattern was similar in unstimulated WF rat platelets, except that the large membrane complexes present in the cytoplasm of these cells contained little or no talin (Fig 1, A and B) , as was the case with WF megakaryocytes! The immunogold particle distribution for talin was then quantitatively analyzed. Gold particle localization was categorized into that on plasma or granule membranes, or within 100 nm of these organelles, and other, including SCCS, mitochondria, and cytosol. SCCS could not always be precisely identified in frozen-thin sections and, therefore, was not defined as a separate category. The total number of gold particles per platelet was higher for WF than Wistar because WF platelet size is larger (Table 1) . A somewhat lower percentage of talin was found on plasma and granule membranes with a higher percentage in the other category of WF compared with Wistar platelets.
To confirm membrane association of talin in resting platelets, platelet subcellular fractions were prepared by sucrose density fractionation of platelet homogenates, and analyzed for cytoskeletal proteins by biochemical and immunochemical means.
Ultrastructural morphology of Wistar and WF subcellular platelet fractions. The organelles in the platelet homogenates distributed into four regions in the linear sucrose density gradients, which along with the supernatant material above the sucrose gradient, were collected for analysis (Fig   2) . Fractions 2 through 4 of WF rat platelets were consistently less dense than those of Wistar rat platelets in three experiments.
The density fractions were first characterized for their ultrastructural morphology by transmission electron microscopy (Fig 3) . Fraction 1 of Wistar and WF platelets was For (Fig 4) and fibrinogen (Fig 5 ) in these, relative to the other fractions. The relative amounts of these two proteins in the various density fractions also is an indicator of the quality of the homogenization and fractionation procedures. Only minimal amounts of thrombospondin and fibronogen were present in the supernatants indicating that most of the a-granules remained intact after the homogenization procedure, and in addition, that platelet activation as evidenced by a-granule release was not induced by the homogenization process. Only low levels of thrombospondin and fibronogen were found in fraction I, confirming that this fraction is composed mainly of platelet plasma and SCCS membranes (Figs 4 and S) . Some thrombospondin and fibrinogen were present in fraction 2, indicating that this fraction was slightly contaminated with a-granules. This is not surprising, because fraction 2 was not well separated from fraction 3, and consequently. these two fractions were difficult to differentiate.
Cvtoskeletal protein prolfiles of Wistar and WF rat platelet fractions. The platelet fractions were examined for the major cytoskeletal proteins involved in the structural organization of platelets, namely, actin-binding protein (ABP), talin. myosin. vinculin. and actin. The quantity of each protein was determined in Coomassie blue-stained SDS-PAGE gels, and expressed as a percent of total OD of all proteins. The results from two experiments are presented in Table 2 . The protein profiles for unfractionated Wistar and WF platelets were similar except for the decrease in a-granule proteins in WF rat platelets (Fig 4) . In particular, the relative quantities of ABP, talin. myosin, vinculin, and actin were quite similar in unfractionated Wistar and WF rat platelets (Fig 4,  Table 2 ). Consistent with our ultrastructural immunogold analyses, talin was present in all subcellular fractions as well as the supernatant of both Wistar and WF platelets. Although the relative concentrations of talin varied among the fractions, Wistar and WF platelets showed similar talin concentrations within fractions. Talin comprised 8.6% to 10.3% of total protein in unfractionated rat platelets (Table 2) . Of the subcellular organelle fractions, talin was most prevalent in fraction I , the membrane fraction, where it represented 5.6% and 5.7%. respectively, of total Wistar and WF platelet protein. The lowest talin concentration was found in fraction 4 where it comprised 1.1 % of total protein. Talin concentration was highest in the supernatant where it comprised 9.7% to 12.9% of total protein.
Calculation of the talin in each subcellular fraction (OD X fraction volume) expressed as a percentage of the total talin in all fractions revealed that 39% to 58% of all talin was associated with the subcellular organelle fractions (fractions 1 through 4) indicating that approximately one half of the talin is organelle-associated in resting platelets disrupted using a French pressure cell. Of the subcellular organelle fractions, the highest percentage of talin was in fraction I.
The distribution of vinculin, a cytoskeletal protein that binds to talin. mimicked that of talin with 38% to 52% of total vinculin associated with the subcellular organelle fractions. Another cytoskeletal protein, ABP, which acts as a link between platelet membrane glycoprotein Ib and actin filaments, was present in all density fractions and the supernatant, but in contrast to talin and vinculin, most of ABP was organelle-associated (91% to 96%). In contrast with talin, vinculin, and ABP, actin showed the highest relative concentrations in fraction 1.
As indicated above, the amounts of myosin heavy chain in unfractionated Wistar and WF platelets were nearly identical; however, the subcellular distribution of myosin differed between Wistar and WF platelets. Myosin was present in the highest relative concentration in fraction 1 in platelets of both rat strains. However, the concentration of myosin heavy chain in fraction 1 of Wistar platelets was twice that in fraction 1 of WF platelets. This strain difference in fraction 1 myosin concentration was balanced by an almost fourfoldhigher relative concentration of myosin heavy chain in WF platelet fraction 4 separation by SDS-PAGE in 7.5% t o 15% linear polyacrylamide gradients and transfer t o nitrocellulose. Talin, vinculin, myosin heavy chain, and actin were labeled with MoAbs. Fibrinogen was labeled with an affinity-purified polyclonal antibody t o human fibrinogen. Antibody binding was detected with alkaline phosphatase-conjugated goatantimouse lgG for MoAbs, or with second antibody conjugated t o horseradish peroxidase (HRP-conjugated donkey-antigoat lgGl for polyclonal fibrinogen antibody detection by the ECL method. PL, whole platelets; PL fractions, subcellular fractions after platelet disruption in a French pressure cell and separation by ultracentrifugation in linear sucrose gradients; Sup, supernatant (numbers correspond t o platelet subcellular fractions in Fig 2) ; MW, molecular weight (numbers indicate molecular weights of protein standards run in same gel); W, Wistar rat; WF, Wistar Furth.
For branes of WF compared with Wistar platelets. These differences are consistent with the biochemical observations. The identity and relative amounts of talin, myosin, vinculin, and actin were verified by immunoblotting with specific MoAbs (Fig 5) . We did not have access to an antibody that cross-reacts with rat actin-binding protein. Along with the intact proteins, these immunoblots show the presence of degradation products of talin in both unfractionated platelets and the platelet subcellular fractions, and in the case of vinculin, in the subcellular fractions. a-granule membranes; the WF talin distribution in these subcellular fractions did not differ from normal. However, the distribution of myosin differed markedly between WF and Wistar platelet subcellular fractions 1 and 4, with the proportion of myosin decreased to approximately one half of normal in WF platelet fraction 1, with a corresponding increase in WF platelet fraction 4. Myosin distribution analyzed by an ultrastructural immunogold method also showed a lower level of myosin association with plasma membranes, but higher granule localization.
Our focus on platelet cytoskeletal proteins, and talin in particular, was prompted by (1) our interest in elucidating the molecular basis for the platelet formation defect in the WF rat, (2) our finding of membrane blebbing in WF rat megakaryocytes,4 and (3) our detection of a unique antigenic determinant on WF rat talin4 that we subsequently have shown to be caused by a talin missense mutation.' Our earlier ultrastructural immunogold analysis had showed membrane association of talin in megakaryocytes:
whereas another group concluded from ultrastructural immunogold analyses that talin was not associated with platelet plasma membrane~.'~ Therefore, our combined biochemical and ultrastructural immunogold approach was designed to determine whether talin was dissociating from the membranes after platelet formation. Results from both these approaches indicate that a major portion of talin is membrane-associated in platelets as well.
The difference in the conclusions of our and the previo~s'~ platelet talin localization studies may lie in the method of immunogold particle distribution analysis. In the previous study, gold particles were analyzed for their distance from the plasma membraneI5; thus, the localization of gold parti-
DISCUSSION
This study was designed to answer two questions concerning the cytoskeleton of unstimulated platelets. First, is talin membrane-associated in resting platelets? Second, are abnormalities in cytoskeletal proteins detectable in the WF rat? Ultrastructural immunogold analyses showed that a substantial portion of talin was membrane-associated in both normal and WF rat platelets, and, in addition, showed the near absence of talin from the large membrane complexes present in WF rat platelets. To examine the membrane association of platelet cytoskeletal proteins, a detailed biochemical analysis was performed of subcellular fractions of Wistar and WF cles with respect to other platelet membrane systems including the SCCS and granule membranes, both of which show talin association in our studies, was not a part of the analysis.
The lack of talin labeling of the large membrane complexes of WF platelets remains unexplained, but may reflect an absence of membrane skeletal proteins with which talin associates. These membrane complexes consist of both SCCS and smooth endoplasmic reticulum" as Breton-Gorius reported for the large membrane complexes of platelets from patients with hereditary ma~rothrombocytopenias?~ Although ultrastructural immunogold analyses showed a substantial membrane-association of talin in both Wistar and WF platelets, a somewhat lower proportion of talin was present on plasma and granule membranes of WF platelets. This agrees with the abnormal talin distribution in WF megakaryocytes: The smaller proportion of granule membraneassociated talin in WF platelets also may be related to the smaller size and number of WF a-granules.
Our biochemical analyses also indicated that talin is associated with subcellular organelles in both normal and WF rat resting platelets, but no difference was detected in the distribution of WF and Wistar talin among the subcellular fractions. A possible explanation for the discrepancy between the irnmunogold and biochemical talin distributions is that specific membranes are not well resolved by the densitygradient methods.
Approximately one half of talin was present in the subcellular organelle fractions, implying that this organelle-associated talin is complexed to other proteins. Biochemical studies showing direct binding of talin to actin filament^'"^ and membrane proteins? coupled with our demonstration of organelle association, suggests that talin serves as a structural protein in resting platelets, perhaps as a linker of actin filaments to membrane proteins as is postulated to be the case in focal contacts of adherent
The distribution of vinculin in the subcellular fractions paralleled that of talin with approximately equal amounts in the subcellular organelles and supernatant. This may be related to the fact that vinculin binds to talin in v i t r~~~"~ and, presumably, in vivo. Recent studies imply that vinculin becomes associated with talin after talin binds to actin filaments as focal adhesions form on adherent
The finding of vinculin in the a-granule-enriched fractions is consistent with an earlier ultrastructural demonstration of vinculin localization beneath the plasma membrane and association with platelet a-granules, mainly with a-granule membrane^.^'
In comparison to talin and vinculin, a much larger amount (91 %-96%) of ABP was associated with platelet organelles. ABP links the actin membrane skeleton to the platelet membrane via glycoprotein Ib:2*33 which suggests that ABP plays a major role in stabilizing and defining the three-dimensional platelet structure, and, thus, provides the strongest connection between the platelet membrane and the membrane skeleton." If talin and ABP both act as linkers between the membrane and the membrane skeleton, why is more ABP than talin organelle-associated? One explanation may be that ABP has a higher affinity for actin filaments than talin. Alternatively, actin filaments are attached to the platelet membrane skeleton by both their sides and ends." Perhaps ABP links the ends of actin filaments to the membrane, whereas talin mediates the interaction of membranes with the sides of actin filaments. In any case, the high-affinity ABP-membranemembrane skeletal linkages may provide the stable framework for the platelet me~nbrane:~.~~ whereas the talin-membrane-membrane skeletal interactions are of lower affinity and, therefore, more dynamic to allow membrane flexibility.
The significant difference in distribution of WF platelet myosin by ultrastructural immunogold and subcellular biochemical analysis may be explained by a defect or abnormality in the subcellular distribution of one of the myosin classes, an abnormality in the distribution of some protein to which myosin may be binding, or myosin binding to different proteins in subcellular fraction 1 versus fraction 4. For instance, WF platelets may be deficient in a myosin subclass that binds preferentially to membranes in subcellular fraction 1. Alternatively, if one assumes that the primary platelet protein with which myosin interacts is actin, then perhaps the difference in WF platelet myosin subcellular distribution may reflect a difference in the subcellular distribution of actin isotypes in WF versus normal rat platelets. Another possibility is that the differing myosin distribution of WF platelet subcellular fractions may result from a difference in the levels or distribution of proteins that regulate actin-myosin interactions such as tropomyosin; however, treatment of resting platelets with adenosine triphosphate does not affect the ultrastructural distribution of myosin, suggesting that membrane-associated myosin may not be linked to actin filaments. 34 In summary, approximately one half of talin is associated with platelet subcellular fractions in unstimulated Wistar and WF rat platelets disrupted in a French pressure cell. The localization of talin in WF rat platelets beneath plasma mem- branes, along the cytoplasmic side of the SCCS, and on agranule membranes was similar to that of normal rat platelets with the exception that the large cytoplasmic membrane complexes of WF platelets were nearly devoid of talin. Finally, the distribution of myosin between plasma and granule membranes, and among platelet subcellular fractions of WF rat platelets differed from that of normal. These results are consistent with our hypothesis that platelet formation abnormalities of the WF rat are related to defects in the cytoskeleton.
